Literature DB >> 7508108

Kinetic analysis of molecular interconversion of immunosuppressant FK506 by high-performance liquid chromatography.

T Nishikawa1, H Hasumi, S Suzuki, H Kubo, H Ohtani.   

Abstract

High-performance liquid chromatography of FK506, a macrolide immunosuppressant, was performed on a reversed-phase column. The peak was broad with the column kept at room temperature, which was accounted for by slow interconversion between the two forms of FK506. With the use of a heated column, a sharp peak was observed because of the rapid interconversion at high temperature. When the column was cooled to 0 degree C, two sharp peaks were observed because essentially no interconversion occurred at 0 degree C during elution. Analysis of the chromatograms obtained at various eluant flow rates indicated that the conversion of the two forms follows first-order kinetics, and the apparent activation energies for the conversions were calculated. The interconvertibility between the two molecular forms may be related to the immunosuppressive activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508108     DOI: 10.1023/a:1018938618032

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

Review 1.  Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring.

Authors:  L M Shaw
Journal:  Clin Chem       Date:  1989-07       Impact factor: 8.327

2.  Pharmacokinetics of FK 506: preclinical and clinical studies.

Authors:  R Venkataramanan; A Jain; E Cadoff; V Warty; K Iwasaki; K Nagase; A Krajack; O Imventarza; S Todo; J J Fung
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate.

Authors:  M K Rosen; R F Standaert; A Galat; M Nakatsuka; S L Schreiber
Journal:  Science       Date:  1990-05-18       Impact factor: 47.728

Review 4.  Chemistry and biology of the immunophilins and their immunosuppressive ligands.

Authors:  S L Schreiber
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

5.  Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex.

Authors:  G D Van Duyne; R F Standaert; P A Karplus; S L Schreiber; J Clardy
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

6.  Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.

Authors:  S Sawada; G Suzuki; Y Kawase; F Takaku
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

Review 7.  Optimizing cyclosporine therapy: dose, levels, and monitoring.

Authors:  P A Keown
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

8.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.

Authors:  J J Siekierka; S H Hung; M Poe; C S Lin; N H Sigal
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

9.  A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.

Authors:  M W Harding; A Galat; D E Uehling; S L Schreiber
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

10.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

Authors:  J Liu; J D Farmer; W S Lane; J Friedman; I Weissman; S L Schreiber
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

  10 in total
  1 in total

1.  Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing.

Authors:  Kirk A Overhoff; Jason T McConville; Wei Yang; Keith P Johnston; Jay I Peters; Robert O Williams
Journal:  Pharm Res       Date:  2007-10-30       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.